These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23539065)

  • 1. An observational and descriptive study of the epidemiology of and therapeutic approach to onychomycosis in dermatology offices in Brazil.
    Di Chiacchio N; Suarez MV; Madeira CL; Loureiro WR
    An Bras Dermatol; 2013 Feb; 88 Suppl 1():3-11. PubMed ID: 23539065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and management of onychomycosis in private dermatological practice in France].
    Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M
    Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Onychomycosis, what is new in 2014?].
    Baran R; Chabasse D
    J Mycol Med; 2014 Dec; 24(4):245-6. PubMed ID: 25458360
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and risk factors for onychomycosis in acute care dermatology wards.
    Inoue T; Watabe D; Furukawa M; Goto M; Kamada H; Sato Y; Arakawa N; Miura S; Sato T; Yasuhira S; Tsunemi Y; Amano H
    J Dermatol; 2024 Aug; 51(8):1079-1082. PubMed ID: 38558466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification.
    Papini M; Piraccini BM; Difonzo E; Brunoro A
    Mycoses; 2015 Nov; 58(11):659-64. PubMed ID: 26412300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-aetiologic profile of Onychomycoses in a tertiary care centre in northeast India.
    Banik A; Durairaj E; Lyngdoh WV; Khyriem AB; Sabhapandit D
    Trop Doct; 2018 Apr; 48(2):136-142. PubMed ID: 29078738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in laboratory-diagnosed onychomycosis between 2006 and 2014 in the South West of England.
    Wlodek C; Trickey A; de Berker D; Johnson EM
    Br J Dermatol; 2017 Jan; 176(1):237-240. PubMed ID: 27293087
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiological aspects of patients with ungual and cutaneous lesions caused by Scytalidium spp.
    Xavier AP; Oliveira JC; Ribeiro VL; Souza MA
    An Bras Dermatol; 2010; 85(6):805-10. PubMed ID: 21308303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic and clinicomycologic profile of onychomycosis from north India.
    Sarma S; Capoor MR; Deb M; Ramesh V; Aggarwal P
    Int J Dermatol; 2008 Jun; 47(6):584-7. PubMed ID: 18477149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.
    Hilmioğlu-Polat S; Metin DY; Inci R; Dereli T; Kilinç I; Tümbay E
    Mycopathologia; 2005 Sep; 160(2):125-8. PubMed ID: 16170607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Onychomycosis mycological profile in Abidjan (Cote d'Ivoire)].
    Konate A; Yavo W; Kassi KF; Djohan V; Angora KE; Bosson-Vanga H; Barro-Kiki P; E I H Menan
    J Mycol Med; 2014 Sep; 24(3):205-10. PubMed ID: 24751943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Onychomycosis in Casablanca (Morocco)].
    Halim I; El Kadioui F; Soussi Abdallaoui M
    J Mycol Med; 2013 Mar; 23(1):9-14. PubMed ID: 23287730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Fungal Species of Onychomycosis between Diabetic and Non-Diabetic Patients.
    Sultana S; Jaigirdar QH; Islam MA; Azad AK
    Mymensingh Med J; 2018 Oct; 27(4):752-756. PubMed ID: 30487490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Onychomycoses due to molds].
    Chabasse D; Pihet M
    J Mycol Med; 2014 Dec; 24(4):261-8. PubMed ID: 25458362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015.
    Otašević S; Barac A; Pekmezovic M; Tasic S; Ignjatović A; Momčilović S; Stojanović P; Arsic Arsenijevic V; Hay R
    Mycoses; 2016 Mar; 59(3):167-72. PubMed ID: 26710983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis in Iran: epidemiology, causative agents and clinical features.
    Aghamirian MR; Ghiasian SA
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(1):23-9. PubMed ID: 20185868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis in Cali, Colombia.
    Alvarez MI; González LA; Castro LA
    Mycopathologia; 2004 Aug; 158(2):181-6. PubMed ID: 15518346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: Clinical overview and diagnosis.
    Lipner SR; Scher RK
    J Am Acad Dermatol; 2019 Apr; 80(4):835-851. PubMed ID: 29959961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis: diagnosis and systemic treatment.
    Milles CL; Riley PA; Kessenich CR
    Nurse Pract; 1998 Dec; 23(12):40-2, 45-8, 51. PubMed ID: 9879077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.